HOME Top Market Reports Cell Dissociation Market by Product (Enzymatic (Collagenase, Trypsin, DNase, Elastase) Non-enzymatic), Type (Tissue Dissociation), Tissue (Connective, Epithelial), End User (Pharmaceutical, Research Institutes) - Global Forecast to 2023

Cell Dissociation Market by Product (Enzymatic (Collagenase, Trypsin, DNase, Elastase) Non-enzymatic), Type (Tissue Dissociation), Tissue (Connective, Epithelial), End User (Pharmaceutical, Research Institutes) - Global Forecast to 2023

By: marketsandmarkets.com
Publishing Date: March 2018
Report Code: BT 6129

 

  Speak to Analyst Enquiry Before Buying Webinar
purchase report
download pdf  request for customisation


The cell dissociation market is expected to reach USD 440.5 Million by 2023 from USD 214.1 Million in 2017, at a CAGR of 12.8%. The base year for this study is 2017 and the forecast period is 2018–2023.

The objectives of this study are as follows:

  • To define, describe, and forecast the cell dissociation market by product, tissue, type, end user, and region
  • To forecast the revenue of the market segments with respect to four main regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW)
  • To identify micromarkets and the drivers, opportunities, and trends affecting the growth of the market
  • To strategically analyze market segments and subsegments with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To profile key players and comprehensively analyze their market shares and core competencies in terms of market developments and growth strategies
  • To track and analyze competitive developments such as agreements; acquisitions; expansions; and R&D activities in the cell dissociation market

Research Methodology

Top-down and bottom-up approaches were used to estimate and validate the size of the market and the size of various other dependent submarkets. The overall market size was used in the top-down approach to estimate the sizes of other individual submarkets (mentioned in the market segmentation—by type and region) through percentage splits from secondary and primary research. The bottom-up approach was also implemented (wherever applicable) for data extracted from secondary research to validate the market segment revenues obtained.

Various secondary sources such as the Department of Health and Social Care (DHSC), National Cancer Institute (NCI), European Association for Cancer Research, American Association for Cancer Research, Asian Clinical Oncology Society, Israel Cancer Research Fund (ICRF), Breast Cancer Research Foundation (BCRF), National Centre for Cell Science (NCCS), American Society for Cell Biology, International Society for Stem Cell Research, International Society for Cellular Therapy, and PubMed have been used to identify and collect information useful for this extensive commercial study of the market. Primary sources such as experts from related industries and suppliers have been interviewed to obtain and verify critical information as well as to assess the prospects of the cell dissociation market. The breakdown of profiles of primaries is shown in the figure below:

Cell Dissociation Market

To know about the assumptions considered for the study, download the pdf brochure

The major players in the cell dissociation market include Thermo Fisher Scientific (US), Merck KGaA (Germany), Roche (Switzerland), Miltenyi Biotec (Germany), HiMedia Laboratories (India), STEMCELL Technologies (Canada), BD (US), ATCC (US), PAN-Biotech (Germany), and GE Healthcare (US).

Target Audience for this Report:

  • Manufacturers and vendors of cell dissociation products
  • Distributors of cell dissociation products
  • Venture capitalists
  • Various research and consulting firms
  • Research & academic institutes
  • Pharmaceutical & biotechnology companies

Scope of the Report:

This report categorizes the cell dissociation market into the following segments:

  • Cell Dissociation Market, By Product

    • Enzymatic Dissociation Products
      • Collagenase
      • Trypsin
      • Elastase
      • Papain
      • Hyaluronidase
      • DNase
      • Other Enzymes
    • Non-enzymatic Dissociation Products
    • Instruments & Accessories
  • Cell Dissociation Market, By Tissue

    • Connective Tissue
    • Epithelial Tissue
    • Other Tissue
  • Cell Dissociation Market, By Type 

    • Tissue Dissociation
    • Cell Detachment
  • Cell Dissociation Market, By End User 

    • Pharamceutical & Biotechnological Companies
    • Research & Academic Institutes
    • Other End Users
  • Cell Dissociation Market, By Region

    • North America
      • US
      • Canada
    • Europe
    • Asia Pacific
      • Japan
      • China
      • India
      • Rest of Asia Pacific
    • Rest of the World

Customization Options:

  • Company Information: Detailed company profiles of five or more market players
  • Opportunity Assessment: A detailed report underlining the various growth opportunities presented in the market

Table of Contents

1 Introduction (Page No. - 11)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 14)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
    2.2 Market Size Estimation
           2.2.1 Bottom-Up Approach
           2.2.2 Top-Down Approach
    2.3 Market Breakdown and Data Triangulation
    2.4 Assumptions for the Study

3 Executive Summary (Page No. - 22)

4 Premium Insights (Page No. - 26)
    4.1 Cell Dissociation Market Overview
    4.2 Asia Pacific: Cell Dissociation Market, By Product & Country
    4.3 Cell Dissociation Market, By Region
    4.4 Geographical Snapshot of the Cell Dissociation Market (Major Countries)

5 Market Overview (Page No. - 30)
    5.1 Introduction
    5.2 Cell Dissociation Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Increasing R&D Activities in Biopharmaceutical Companies
                    5.2.1.2 Favorable Funding Scenario for Cancer Research
           5.2.2 Opportunity
                    5.2.2.1 Growth Opportunities in Emerging Markets
           5.2.3 Trends
                    5.2.3.1 Emergence of Advanced Tissue Dissociation Enzyme Products
                    5.2.3.2 Acceptance of Enzyme-Free Dissociation Products Over Enzymatic Dissociation Products

6 Cell Dissociation Market, By Product (Page No. - 34)
    6.1 Introduction
    6.2 Enzymatic Dissociation Products
           6.2.1 Collagenase
           6.2.2 Trypsin
           6.2.3 Papain
           6.2.4 Elastase
           6.2.5 Dnase
           6.2.6 Hyaluronidase
           6.2.7 Other Enzymes
    6.3 Non-Enzymatic Dissociation Products
    6.4 Instruments & Accessories

7 Cell Dissociation Market, By Tissue (Page No. - 46)
    7.1 Introduction
    7.2 Connective Tissue
    7.3 Epithelial Tissue
    7.4 Other Tissue

8 Cell Dissociation Market, By Type (Page No. - 51)
    8.1 Introduction
    8.2 Tissue Dissociation
    8.3 Cell Detachment

9 Cell Dissociation Market, By End User (Page No. - 54)
    9.1 Introduction
    9.2 Pharmaceutical & Biotechnology Companies
    9.3 Research & Academic Institutes
    9.4 Other End Users

10 Cell Dissociation Market, By Region (Page No. - 61)
     10.1 Introduction
     10.2 North America
             10.2.1 US
             10.2.2 Canada
     10.3 Europe
     10.4 Asia Pacific
             10.4.1 Japan
             10.4.2 China
             10.4.3 India
             10.4.4 Rest of Asia Pacific
     10.5 Rest of the World

11 Competitive Landscape (Page No. - 84)
     11.1 Overview
     11.2 Market Ranking Analysis
     11.3 Competitive Scenario
             11.3.1 Expansions
             11.3.2 Acquisitions
             11.3.3 Agreements

12 Company Profiles (Page No. - 87)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
     12.1 BD
     12.2 Thermo Fisher Scientific
     12.3 F. Hoffmann-La Roche Ltd.
     12.4 GE Healthcare
     12.5 Merck KGaA
     12.6 ATCC
     12.7 Himedia Laboratories
     12.8 Pan-Biotech
     12.9 Miltenyi Biotec
     12.10 Stemcell Technologies

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. - 104)
     13.1 Insights of Industry Experts
     13.2 Discussion Guide
     13.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     13.4 Introducing RT: Real-Time Market Intelligence
     13.5 Available Customizations
     13.6 Related Reports
     13.7 Author Details


List of Tables (75 Tables)

Table 1 R&D Expenditure of Major Biopharmaceutical Companies, 2015 vs 2016
Table 2 Cell Dissociation Market, By Product, 2016–2023 (USD Million)
Table 3 Enzymatic Dissociation Products Market, By Type, 2016–2023 (USD Million)
Table 4 Collagenase Market, By Region, 2016–2023 (USD Million)
Table 5 North America: Collagenase Market, By Country, 2016–2023 (USD Million)
Table 6 Trypsin Market, By Region, 2016–2023 (USD Million)
Table 7 North America: Trypsin Market, By Country, 2016–2023 (USD Million)
Table 8 Papain Market, By Region, 2016–2023 (USD Million)
Table 9 North America: Papain Market, By Country, 2016–2023 (USD Million)
Table 10 Elastase Market, By Region, 2016–2023 (USD Million)
Table 11 North America: Elastase Market, By Country, 2016–2023 (USD Million)
Table 12 Dnase Market, By Region, 2016–2023 (USD Million)
Table 13 North America: Dnase Market, By Country, 2016–2023 (USD Million)
Table 14 Hyaluronidase Market, By Region, 2016–2023 (USD Million)
Table 15 North America: Hyaluronidase Market, By Country, 2016–2023 (USD Million)
Table 16 Other Enzymes Market, By Region, 2016–2023 (USD Million)
Table 17 North America: Other Enzymes Market, By Country, 2016–2023 (USD Million)
Table 18 Non-Enzymatic Dissociation Products Market, By Region, 2016–2023 (USD Million)
Table 19 North America: Non-Enzymatic Dissociation Products Market, By Country, 2016–2023 (USD Million)
Table 20 Instruments & Accessories Market, By Region, 2016–2023 (USD Million)
Table 21 North America: Instruments & Accessories Market, By Country, 2016–2023 (USD Million)
Table 22 Cell Dissociation Market, By Tissue Type, 2016–2023 (USD Million)
Table 23 Cell Dissociation Market for Connective Tissue, By Region, 2016–2023 (USD Million)
Table 24 Cell Dissociation Market for Epithelial Tissue, By Region, 2016–2023 (USD Million)
Table 25 Cell Dissociation Market for Other Tissue, By Region, 2016–2023 (USD Million)
Table 26 Cell Dissociation Market, By Application, 2016–2023 (USD Million)
Table 27 Tissue Dissociation Market, By Region, 2016–2023 (USD Million)
Table 28 Cell Detachment Market, By Region, 2016–2023 (USD Million)
Table 29 Cell Dissociation Market, By End User, 2016–2023 (USD Million)
Table 30 Cell Dissociation Market for Pharmaceutical & Biotechnology Companies, By Region, 2016–2023 (USD Million)
Table 31 North America: Cell Dissociation Market for Pharmaceutical & Biotechnology Companies, By Country, 2016–2023 (USD Million)
Table 32 Asia Pacific: Cell Dissociation Market for Pharmaceutical & Biotechnology Companies, By Country, 2016–2023 (USD Million)
Table 33 Cell Dissociation Market for Research & Academic Institutes, By Region, 2016–2023 (USD Million)
Table 34 North America: Market for Research & Academic Institutes, By Country, 2016–2023 (USD Million)
Table 35 Asia Pacific: Market for Research & Academic Institutes, By Country, 2016–2023 (USD Million)
Table 36 Cell Dissociation Market for Other End Users, By Region, 2016–2023 (USD Million)
Table 37 North America: Market for Other End Users, By Country, 2016–2023 (USD Million)
Table 38 Asia Pacific: Market for Other End Users, By Country, 2016–2023 (USD Million)
Table 39 Market, By Region, 2016–2023 (USD Million)
Table 40 North America: Market, By Country, 2016–2023 (USD Million)
Table 41 North America: Market, By Product, 2016–2023 (USD Million)
Table 42 North America: Enzymatic Dissociation Products Market, By Type, 2016–2023 (USD Million)
Table 43 North America: Market, By End User, 2016–2023 (USD Million)
Table 44 US: Market, By Product, 2016–2023 (USD Million)
Table 45 US: Enzymatic Dissociation Products Market, By Type, 2016–2023 (USD Million)
Table 46 US: Market, By End User, 2016–2023 (USD Million)
Table 47 Canada: Market, By Product, 2016–2023 (USD Million)
Table 48 Canada: Enzymatic Dissociation Products Market, By Type, 2016–2023 (USD Million)
Table 49 Canada: Market, By End User, 2016–2023 (USD Million)
Table 50 Europe: Market, By Product, 2016–2023 (USD Million)
Table 51 Europe: Enzymatic Dissociation Products Market, By Type, 2016–2023 (USD Million)
Table 52 Europe: Market, By End User, 2016–2023 (USD Million)
Table 53 Asia Pacific: Market, By Country, 2016–2023 (USD Million)
Table 54 Asia Pacific: Market, By Product, 2016–2023 (USD Million)
Table 55 Asia Pacific: Enzymatic Dissociation Products Market, By Type, 2016–2023 (USD Million)
Table 56 Asia Pacific: Market, By End User, 2016–2023 (USD Million)
Table 57 Japan: Market, By Product, 2016–2023 (USD Million)
Table 58 Japan: Enzymatic Dissociation Products Market, By Type, 2016–2023 (USD Million)
Table 59 Japan: Market, By End User, 2016–2023 (USD Million)
Table 60 China: Market, By Product, 2016–2023 (USD Million)
Table 61 China: Enzymatic Dissociation Products Market, By Type, 2016–2023 (USD Million)
Table 62 China: Market, By End User, 2016–2023 (USD Million)
Table 63 India: Market, By Product, 2016–2023 (USD Million)
Table 64 India: Enzymatic Dissociation Products Market, By Type, 2016–2023 (USD Million)
Table 65 India: Market, By End User, 2016–2023 (USD Million)
Table 66 RoAPAC: Market, By Product, 2016–2023 (USD Million)
Table 67 RoAPAC: Enzymatic Dissociation Products Market, By Type, 2016–2023 (USD Million)
Table 68 RoAPAC: Market, By End User, 2016–2023 (USD Million)
Table 69 RoW: Market, By Product, 2016–2023 (USD Million)
Table 70 RoW: Enzymatic Dissociation Products Market, By Type, 2016–2023 (USD Million)
Table 71 RoW: Market, By End User, 2016–2023 (USD Million)
Table 72 Top 5 Companies in the Market
Table 73 Expansions, 2014–2017
Table 74 Acquisitions, 2014–2017
Table 75 Agreements, 2014–2017


List of Figures (27 Figures)

Figure 1 Research Design
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Market Size Estimation Methodology: Bottom-Up Approach
Figure 4 Market Size Estimation Methodology: Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Market, By Product, 2018 vs 2023 (USD Million)
Figure 7 Market, By Tissue Type, 2018 vs 2023 (USD Million)
Figure 8 Market, By Application, 2018 vs 2023 (USD Million)
Figure 9 Market, By End User, 2018 vs 2023 (USD Million)
Figure 10 Market, By Region, 2018 vs 2023 (USD Million)
Figure 11 Increasing R&D Investments By Pharma Companies, and Rising Funding for Chronic Disease Research to Drive Market Growth
Figure 12 Enzymatic Dissociation Products to Account for the Largest Market Share in 2017
Figure 13 North America Expected to Register the Highest Market Share in 2017
Figure 14 India to Register the Highest CAGR During the Forecast Period
Figure 15 Market: Drivers, Opportunities, and Trends
Figure 16 Enzymatic Dissociation Products to Dominate the Cell Dissociation Market During the Forecast Period
Figure 17 Connective Tissue Segment Will Continue to Dominate the Cell Dissociation Market in 2023
Figure 18 Pharmaceutical & Biotechnology Companies to Dominate the Cell Dissociation Market During the Forecast Period
Figure 19 North America to Dominate the Global Cell Dissociation Market in 2018
Figure 20 North America: Market Snapshot
Figure 21 Asia Pacific: Market Snapshot
Figure 22 Expansions - Key Strategy Adopted By Players Between 2014 and 2017
Figure 23 BD: Company Snapshot (2017)
Figure 24 Thermo Fisher Scientific: Company Snapshot (2016)
Figure 25 F. Hoffmann-La Roche Ltd: Company Snapshot (2017)
Figure 26 GE Healthcare: Company Snapshot (2017)
Figure 27 Merck KGaA: Company Snapshot (2016)

The global cell dissociation market is expected to reach USD 440.5 Million by 2023 from USD 241.2 Million in 2018, at a CAGR of 12.8%. Market growth is primarily driven by the rising R&D investments in the life sciences industry, increasing research on chronic diseases and rising government funding for cancer research.

The global market is segmented by product, tissue, type, end user, and region. By product, the market segmented into enzymatic dissociation products, non-enzymatic dissociation products and instruments & accessories. The enzymatic dissociation products segment estimated to account for the largest market of the global cell dissociation market in 2018.

The end user segment includes pharmaceutical & biotechnology companies, research & academic institutes, and other end users. The pharmaceutical & biotechnology companies segment is estimated to register the highest growth rate and largest market share during the forecast period. This is primarily attributed to increasing demand for enzymatic dissociation products and instruments by these end users.

The tissue segment includes connective tissue, epithelial tissue, and other tissue. Among all, the connective tissue accounted for the largest share of the market in 2017. This is primarily attributed to the increasing research on cancer.

Cell Dissociation Market

The global cell dissociation market is dominated by North America, followed by Europe. North America will continue to dominate the global market in the forecast period, however, Asia Pacific is expected to witness the highest CAGR, with the growth in this market centered on Japan, China, and India. Factors such as the increasing R&D investments and government funding for chronic disease research are driving the market in the region.

Thermo Fisher Scientific (US), Merck KGaA (Germany), Roche (Switzerland), Miltenyi Biotec (Germany), HiMedia Laboratories (India), STEMCELL Technologies (Canada), BD (US), ATCC (US), PAN-Biotech (Germany), and GE Healthcare (US) have been identified as the key players in this market. These companies have broad product portfolios with comprehensive features. These leaders also have products for all end users in this market, a strong geographical presence, and a focus on continuous product innovation. Key industry players are focusing on the expansions of their presence to maintain and enhance their position in the cell dissociation market.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit https://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Biotechnology Markets on KnowledgeStore
Request Demo